![Alex Cross's Trial (Alex Cross Adventures, 1): Patterson, James, DiLallo, Richard: 9780446557788: Amazon.com: Books Alex Cross's Trial (Alex Cross Adventures, 1): Patterson, James, DiLallo, Richard: 9780446557788: Amazon.com: Books](https://m.media-amazon.com/images/I/610WseMtsDL._AC_UF1000,1000_QL80_.jpg)
Alex Cross's Trial (Alex Cross Adventures, 1): Patterson, James, DiLallo, Richard: 9780446557788: Amazon.com: Books
![Frontiers | Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial Frontiers | Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial](https://www.frontiersin.org/files/Articles/917961/fonc-12-917961-HTML/image_m/fonc-12-917961-g001.jpg)
Frontiers | Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
![The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-33192-1/MediaObjects/41467_2022_33192_Fig1_HTML.png)
The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications
![Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer - Mayanagi - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer - Mayanagi - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/64811f34-1de4-4284-97d5-64c51a6d122a/ags312243-fig-0001-m.jpg)
Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer - Mayanagi - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library
![Journal of Clinical Oncology on X: "Survival benefit of preoperative chemoradiotherapy for patients with esophageal cancer persists - 10-year outcome of the CROSS trial https://t.co/s02sMVpYhI #esocsm #JCO @ErasmusMC @bmeyck https://t.co/2JwV0iOvoB" / X Journal of Clinical Oncology on X: "Survival benefit of preoperative chemoradiotherapy for patients with esophageal cancer persists - 10-year outcome of the CROSS trial https://t.co/s02sMVpYhI #esocsm #JCO @ErasmusMC @bmeyck https://t.co/2JwV0iOvoB" / X](https://pbs.twimg.com/media/E0o7QqjWQAEy-u9.jpg)
Journal of Clinical Oncology on X: "Survival benefit of preoperative chemoradiotherapy for patients with esophageal cancer persists - 10-year outcome of the CROSS trial https://t.co/s02sMVpYhI #esocsm #JCO @ErasmusMC @bmeyck https://t.co/2JwV0iOvoB" / X
![Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma | British Journal of Cancer Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-023-02458-w/MediaObjects/41416_2023_2458_Figa_HTML.png)
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma | British Journal of Cancer
![CROSS Trial: Esophageal Cancer, Surgery, and Neoadjuvant Therapy | BTK/RAS-ACS Journal Club #9 - YouTube CROSS Trial: Esophageal Cancer, Surgery, and Neoadjuvant Therapy | BTK/RAS-ACS Journal Club #9 - YouTube](https://i.ytimg.com/vi/F1t5zvShNoc/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLBfpLVypGUM-CJtmPVYgSKkK-ksUA)
CROSS Trial: Esophageal Cancer, Surgery, and Neoadjuvant Therapy | BTK/RAS-ACS Journal Club #9 - YouTube
![Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | Strahlentherapie und Onkologie Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | Strahlentherapie und Onkologie](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00066-020-01594-z/MediaObjects/66_2020_1594_Fig1_HTML.png)
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | Strahlentherapie und Onkologie
![Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | Full Text Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6669-y/MediaObjects/12885_2020_6669_Fig1_HTML.png)
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | Full Text
![Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2113983482/2084460251/gr1.gif)